Media Corner

Outreach kit

Poster

The poster presenting the research findings of the COVend consortium partner, Systems Biology Ireland (UCD), on Fibrin-derived Peptide FX06 Protecting Human Pulmonary Endothelial Cells Against COVID-19-Triggered Cytokines

Press release

The COVend press release available in English and German announces the start of patient enrollment for the IXION 2.0 clinical trial and project's shift to investigating the potential benefits of the FX06 drug for patients with ARDS.

Poster

The two COVend posters explain the technology behind the project in detail and are mainly targeted at a medical and scientific audience but also serve as a project overview for a non-expert audience.

Poster

A poster prepared by Zhiran Wang and the UCD & SBI team presents their findings on mimicking the inflammatory response of COVID-19 in endothelial cells and FX06 reducing the harmful effects of the cytokines on the cells.

Press release

A poster prepared by Clazinus Veijer highlights the results from a systematic review on various methodological characteristics of model-based economic evaluations of COVID-19 treatments conducted by the UMCG team.

Roll-up banner

This COVend roll-up contains all key facts about the project, including links to the project's communication channels.

Factsheet ENG/DEU

This project factsheet informs about the background, objectives, main concept of the project. Available in English and German.

Press release

The first COVend press release presents the background and objectives of the project and announces it to a broad audience.